Skip to main content
PMC home page
Gut logoLink to Gut
. 1992 Feb;33(2):252–255. doi: 10.1136/gut.33.2.252

Prophylactic effects of olsalazine v sulphasalazine during 12 months maintenance treatment of ulcerative colitis. The Danish Olsalazine Study Group.

S Kiilerich 1, K Ladefoged 1, T Rannem 1, P J Ranløv 1
PMCID: PMC1373939  PMID: 1347280

Abstract

In a Danish multicentre trial we compared the relapse preventing effects of olsalazine and sulphasalazine in patients with ulcerative colitis over a 12 month treatment period. Two hundred and twenty seven patients (118 men) with at least two previous attacks of ulcerative colitis were randomly allocated according to a prearranged treatment schedule to olsalazine 500 mg bd or sulphasalazine 1 g bd in a double blind, double dummy fashion. One hundred and ninety seven patients completed the trial. The relapse rate after 12 month in the olsalazine group was 46.9% v 42.4% in the sulphasalazine group with a 95% confidence interval for the difference in proportions of -9% to 18%. Seven per cent of the patients were withdrawn from the trial because of adverse drug reactions and these were equally distributed between the two groups.

Full text

PDF
252

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azad Khan A. K., Piris J., Truelove S. C. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet. 1977 Oct 29;2(8044):892–895. doi: 10.1016/s0140-6736(77)90831-5. [DOI] [PubMed] [Google Scholar]
  2. Das K. M., Eastwood M. A. Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):514–520. doi: 10.1002/cpt1975185part1514. [DOI] [PubMed] [Google Scholar]
  3. Dissanayake A. S., Truelove S. C. A controlled therapeutic trial of long-term maintenance treatment of ulcerative colitis with sulphazalazine (Salazopyrin). Gut. 1973 Dec;14(12):923–926. doi: 10.1136/gut.14.12.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Feurle G. E., Theuer D., Velasco S., Barry B. A., Wördehoff D., Sommer A., Jantschek G., Kruis W. Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial. Gut. 1989 Oct;30(10):1354–1361. doi: 10.1136/gut.30.10.1354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Goerg K. J., Wanitschke R., Diehl P. H., Meyer zum Büschenfelde K. H. Secretory effect of azodisalicylate (azodisal sodium) on the short circuited mucosa of the rat ileum in vitro. Gut. 1988 Mar;29(3):336–341. doi: 10.1136/gut.29.3.336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ireland A., Jewell D. P. Olsalazine in patients intolerant of sulphasalazine. Scand J Gastroenterol. 1987 Nov;22(9):1038–1040. doi: 10.3109/00365528708991953. [DOI] [PubMed] [Google Scholar]
  7. Ireland A., Mason C. H., Jewell D. P. Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis. Gut. 1988 Jun;29(6):835–837. doi: 10.1136/gut.29.6.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Meyers S., Sachar D. B., Present D. H., Janowitz H. D. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology. 1987 Dec;93(6):1255–1262. doi: 10.1016/0016-5085(87)90253-8. [DOI] [PubMed] [Google Scholar]
  9. Mohsen A. Q., Mulvey D., Priddle J. D., Parsons D. S., Jewell D. P. Effects of olsalazine in the jejunum of the rat. Gut. 1987 Mar;28(3):346–352. doi: 10.1136/gut.28.3.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pamukcu R., Hanauer S. B., Chang E. B. Effect of disodium azodisalicylate on electrolyte transport in rabbit ileum and colon in vitro. Comparison with sulfasalazine and 5-aminosalicylic acid. Gastroenterology. 1988 Oct;95(4):975–981. doi: 10.1016/0016-5085(88)90172-2. [DOI] [PubMed] [Google Scholar]
  11. Rao S. S., Dundas S. A., Holdsworth C. D., Cann P. A., Palmer K. R., Corbett C. L. Olsalazine or sulphasalazine in first attacks of ulcerative colitis? A double blind study. Gut. 1989 May;30(5):675–679. doi: 10.1136/gut.30.5.675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rao S. S., Read N. W., Holdsworth C. D. Influence of olsalazine on gastrointestinal transit in ulcerative colitis. Gut. 1987 Nov;28(11):1474–1477. doi: 10.1136/gut.28.11.1474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sandberg-Gertzén H., Järnerot G., Bukhave K., Lauritsen K., Rask-Madsen J. Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy. Gut. 1986 Nov;27(11):1306–1311. doi: 10.1136/gut.27.11.1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sandberg-Gertzén H., Järnerot G., Kraaz W. Azodisal sodium in the treatment of ulcerative colitis. A study of tolerance and relapse-prevention properties. Gastroenterology. 1986 Apr;90(4):1024–1030. doi: 10.1016/0016-5085(86)90882-6. [DOI] [PubMed] [Google Scholar]
  15. Selby W. S., Barr G. D., Ireland A., Mason C. H., Jewell D. P. Olsalazine in active ulcerative colitis. Br Med J (Clin Res Ed) 1985 Nov 16;291(6506):1373–1375. doi: 10.1136/bmj.291.6506.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. TRUELOVE S. C., RICHARDS W. C. Biopsy studies in ulcerative colitis. Br Med J. 1956 Jun 9;1(4979):1315–1318. doi: 10.1136/bmj.1.4979.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Taffet S. L., Das K. M. Sulfasalazine. Adverse effects and desensitization. Dig Dis Sci. 1983 Sep;28(9):833–842. doi: 10.1007/BF01296907. [DOI] [PubMed] [Google Scholar]
  18. Watkinson G. Sulphasalazine: a review of 40 years' experience. Drugs. 1986;32 (Suppl 1):1–11. doi: 10.2165/00003495-198600321-00003. [DOI] [PubMed] [Google Scholar]
  19. Zinberg J., Molinas S., Das K. M. Double-blind placebo-controlled study of olsalazine in the treatment of ulcerative colitis. Am J Gastroenterol. 1990 May;85(5):562–566. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES